Breckenridge Pharmaceutical
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- LANSOPRAZOLE BRECKENRIDGE gastro-resistant capsule, hard 15 mg
- LANSOPRAZOLE BRECKENRIDGE gastro-resistant capsule, hard 30 mg
- A04 - Antieméticos y antinauseosos
- GRANISETRON HYDROCHLORIDE BRECKENRIDGE film-coated tablet 1 mg
- C07 - Betabloqueantes
- PROPRANOLOL HCL BRECKENRIDGE prolonged-release capsule, hard 120 mg
- PROPRANOLOL HCL BRECKENRIDGE prolonged-release capsule, hard 160 mg
- PROPRANOLOL HCL BRECKENRIDGE prolonged-release capsule, hard 60 mg
- PROPRANOLOL HCL BRECKENRIDGE prolonged-release capsule, hard 80 mg
- J05 - Antivirales de uso sistémico
- NEVIRAPINE BRECKENRIDGE tablet 200 mg
- L02 - Terapia endocrina
- ANASTROZOLE BRECKENRIDGE tablet 1 mg
- BICALUTAMIDE BRECKENRIDGE film-coated tablet 50 mg
- LETROZOLE BRECKENRIDGE tablet 2.5 mg
- N02 - Analgésicos
- GABAPENTIN BRECKENRIDGE capsule, hard 100 mg
- GABAPENTIN BRECKENRIDGE capsule, hard 300 mg
- GABAPENTIN BRECKENRIDGE capsule, hard 400 mg
- N03 - Antiepilépticos
- OXCARBAZEPINE BRECKENRIDGE film-coated tablet 150 mg
- OXCARBAZEPINE BRECKENRIDGE film-coated tablet 300 mg
- OXCARBAZEPINE BRECKENRIDGE film-coated tablet 600 mg
- N06 - Psicoanalépticos
- METHYLPHENIDATE HCL BRECKENRIDGE oral solution 10 mg/5 ml
- METHYLPHENIDATE HCL BRECKENRIDGE oral solution 5 mg/5 ml
- R06 - Antihistamínicos para uso sistémico
- CARBINOXAMINE MALEATE BRECKENRIDGE oral solution 4 mg/5 ml
- CARBINOXAMINE MALEATE BRECKENRIDGE tablet 4 mg